Factors associated with sinus bradycardia during crizotinib treatment: a retrospective analysis of two large‐scale multinational trials (PROFILE 1005 and 1007)

por Ou, Sai‐Hong Ignatius, Tang, Yiyun, Polli, Anna, Wilner, Keith D., Schnell, Patrick
Publicado 2016

Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non‐small cell lung cancer (NSCLC) in Europe

por Huang, Kui, Madison, Terri, Wehler, Beatrice, Tiseo, Marcello, Wilner, Keith D., Mo, Jingping
Publicado 2020

Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer

por Nishio, Makoto, Kim, Dong-Wan, Wu, Yi-Long, Nakagawa, Kazuhiko, Solomon, Benjamin J., Shaw, Alice T., Hashigaki, Satoshi, Ohki, Emiko, Usari, Tiziana, Paolini, Jolanda, Polli, Anna, Wilner, Keith D., Mok, Tony
Publicado 2018

Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer

por Durairaj, Chandrasekar, Ruiz-Garcia, Ana, Gauthier, Eric R., Huang, Xin, Lu, Dongrui R., Hoffman, Justin T., Finn, Richard S., Joy, Anil A., Ettl, Johannes, Rugo, Hope S., Zheng, Jenny, Wilner, Keith D., Wang, Diane D.
Publicado 2018

Complex renal cysts associated with crizotinib treatment

por Schnell, Patrick, Bartlett, Cynthia H, Solomon, Benjamin J, Tassell, Vanessa, Shaw, Alice T, de Pas, Tommaso, Lee, Soo-Hyun, Lee, Geon Kook, Tanaka, Kaoru, Tan, Weiwei, Tang, Yiyun, Wilner, Keith D, Safferman, Allan, Han, Ji-Youn
Publicado 2015

Final Overall Survival, Safety, and Quality of Life Results From a Phase 2 Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced NSCLC

por Wu, Yi-Long, Lu, Shun, Yang, James Chih-Hsin, Zhou, Jianying, Seto, Takashi, Ahn, Myung-Ju, Su, Wu-Chou, Yamamoto, Noboru, Kim, Dong-Wan, Paolini, Jolanda, Usari, Tiziana, Iadeluca, Laura, Wilner, Keith D., Goto, Koichi
Publicado 2022

Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating...

por Mok, Tony S., Cheng, Ying, Zhou, Xiangdong, Lee, Ki Hyeong, Nakagawa, Kazuhiko, Niho, Seiji, Chawla, Alka, Rosell, Rafael, Corral, Jesus, Migliorino, Maria Rita, Pluzanski, Adam, Noonan, Kay, Tang, Yiyun, Pastel, Malaika, Wilner, Keith D., Wu, Yi-Long
Publicado 2020

Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-...

por Blackhall, Fiona, Ross Camidge, D, Shaw, Alice T, Soria, Jean-Charles, Solomon, Benjamin J, Mok, Tony, Hirsh, Vera, Jänne, Pasi A, Shi, Yuankai, Yang, Pan-Chyr, Pas, Tommaso De, Hida, Toyoaki, Carpeño, Javier De Castro, Lanzalone, Silvana, Polli, Anna, Iyer, Shrividya, Reisman, Arlene, Wilner, Keith D, Kim, Dong-Wan
Publicado 2017

Antitumor Activity of Crizotinib in Lung Cancers Harboring a MET Exon 14 Alteration

por Drilon, Alexander, Clark, Jeffrey W., Weiss, Jared, Ou, Sai-Hong Ignatius, Camidge, D. Ross, Solomon, Benjamin J., Otterson, Gregory A., Villaruz, Liza C., Riely, Gregory J., Heist, Rebecca S., Awad, Mark M., Shapiro, Geoffrey I., Satouchi, Miyako, Hida, Toyoaki, Hayashi, Hidetoshi, Murphy, Danielle A., Wang, Sherry C., Li, Sherry, Usari, Tiziana, Wilner, Keith D., Paik, Paul K.
Publicado 2020